Paper24670321
Modulation of HIV-1 immunity by adjuvants.
Moody MA. Curr Opin HIV AIDS, 2014. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Modulation of HIV-1 immunity by adjuvants. Papers, record 24670321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24670321
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| Adjuvants, Immunologic | Major topic |
| Antibodies, Neutralizing | Major topic |
| HIV Antibodies | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Animals | |
| Disease Models, Animal | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| UM1 AI100645 | NIAID NIH HHS | United States | UM1AI100645 | PubMed and NIH |
Source NIH RePORTER
References95
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8427039 | Immune response of chimpanzees after immunization with the inactivated whole immunodeficiency virus (HIV-1), three different adjuvants and challenge. | Vaccine | 1993 | https://conductscience.org/library/papers/8427039 | PubMed |
| 2 | 16214252 | Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma. | Virus Res | 2006 | https://conductscience.org/library/papers/16214252 | PubMed |
| 3 | 20048709 | Novel adjuvants for B cell immune responses. | Curr Opin HIV AIDS | 2009 | https://conductscience.org/library/papers/20048709 | PubMed |
| 4 | 16464521 | Enhancement of immune responses to an HIV gp120 DNA vaccine by fusion to TNF alpha cDNA. | Vaccine | 2006 | https://conductscience.org/library/papers/16464521 | PubMed |
| 5 | 10649617 | A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320. | Vaccine | 2000 | https://conductscience.org/library/papers/10649617 | PubMed |
| 6 | 24390332 | Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques. | J Virol | 2014 | https://conductscience.org/library/papers/24390332 | PubMed |
| 7 | 8906986 | Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization. | AIDS Res Hum Retroviruses | 1996 | https://conductscience.org/library/papers/8906986 | PubMed |
| 8 | 8013961 | Adjuvant effect of liposomes and adamantylamide dipeptide on antigenicity of entrapped synthetic peptide derived from HIV-1 transmembrane region glycoprotein gp41. | Immunol Lett | 1994 | https://conductscience.org/library/papers/8013961 | PubMed |
| 9 | 22146759 | Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine. | Vaccine | 2012 | https://conductscience.org/library/papers/22146759 | PubMed |
| 10 | 3644145 | Immunization against AIDS in humans. | Nature | 1987 | https://conductscience.org/library/papers/3644145 | PubMed |
| 11 | 15546399 | The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. | Immunol Rev | 2004 | https://conductscience.org/library/papers/15546399 | PubMed |
| 12 | 1538134 | Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. | J Immunol | 1992 | https://conductscience.org/library/papers/1538134 | PubMed |
| 13 | 16971027 | Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag. | Vaccine | 2007 | https://conductscience.org/library/papers/16971027 | PubMed |
| 14 | 23840043 | Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. | J Infect Dis | 2013 | https://conductscience.org/library/papers/23840043 | PubMed |
| 15 | 16740288 | Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine. | Virology | 2006 | https://conductscience.org/library/papers/16740288 | PubMed |
| 16 | 3162762 | A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS. | Nature | 1988 | https://conductscience.org/library/papers/3162762 | PubMed |
| 17 | 7762277 | Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations. | Vaccine | 1995 | https://conductscience.org/library/papers/7762277 | PubMed |
| 18 | 1988506 | Safety and immunogenicity of a genetically engineered human immunodeficiency virus vaccine. | J Infect Dis | 1991 | https://conductscience.org/library/papers/1988506 | PubMed |
| 19 | 17054781 | A reflection on HIV/AIDS research after 25 years. | Retrovirology | 2006 | https://conductscience.org/library/papers/17054781 | PubMed |
| 20 | 9671219 | Adjuvant is required when using Env lipopeptide construct to induce HIV type 1-specific neutralizing antibody responses in mice in vivo. | AIDS Res Hum Retroviruses | 1998 | https://conductscience.org/library/papers/9671219 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42646699 | Advances in Therapeutic Melanoma Vaccines (2010-2025). | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42646699 | PubMed |
| 41837360 | Rational design of next-generation vaccine adjuvants: From molecular mechanisms to hybrid delivery platforms. | Hum Vaccin Immunother | 2026 | https://conductscience.org/library/papers/41837360 | PubMed |
| 37468460 | Vaccine adjuvants: mechanisms and platforms. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37468460 | PubMed |
| 29541072 | Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1. | Front Immunol | 2018 | https://conductscience.org/library/papers/29541072 | PubMed |
| 28387330 | Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy. | Sci Rep | 2017 | https://conductscience.org/library/papers/28387330 | PubMed |
| 28163018 | Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles. | J Immunol Methods | 2017 | https://conductscience.org/library/papers/28163018 | PubMed |
| 26910195 | New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design. | Expert Rev Vaccines | 2016 | https://conductscience.org/library/papers/26910195 | PubMed |
| 25196483 | Mechanisms of HIV protein degradation into epitopes: implications for vaccine design. | Viruses | 2014 | https://conductscience.org/library/papers/25196483 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD40LG | 959 | PubTator's text mining | https://conductscience.org/library/genes/959 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24670321
GET https://conductscience.org/api/papers/v1/24670321/references?page=2